Disogluside
- Level
- Commodity
- Parent
- 51323100
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51323105This classification denotes an anti-lipidemic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8KI671F2NS. European Medicines Agency schedules Disogluside in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07236MIG. Disogluside generally arises in the molecular formula C33H52O8. The term DISOGLUSIDE is an International Non-Proprietary Name or INN. DISOGLUSIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule disogluside under HS 29389090 and SITC 54161. As of Q4 2014, DISOGLUSIDE remains the US FDA Preferred Term for this commodity. Disogluside bears US NLM identifiers UMLS ID C2699784 and NCI Concept Code C78057. SMILES: O1C2C(C3(C(C4C(CC3)C3(C(=CC4)CC(OC4OC(C(O)C(O)C4O)CO)CC3)C)C2)C)C(C21OCC(CC2)C)C.
Same parent
Under 51323100 · 9Activities that produce or sell this
KBLI · 8Inherited from family 51320000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.